[ Price : $8.95]
The FY 2023 GDUFA Science and Research Report examines GDUFA-funded research in eight priority areas affecting generic drug develo...[ Price : $8.95]
CDER, CBER, and CDRH directors tell Congress they need additional legal authorities to be able to continue to provide the services...[ Price : $8.95]
FDA grants Theriva Biologics a fast-track designation for its lead clinical candidate VCN-01 in combination with gemcitabine and n...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America asks FDA to address four issues relating to implementation of the FDA Reautho...[ Price : $8.95]
Vyaire Medical recalls (Class 1) its Twin Tube sample lines, which are used on the Vyntus CPX Cardiopulmonary Exercise Test, due t...[ Price : $8.95]
Federal Register notice: FDA makes available a draft revised guidance entitled Studies to Evaluate the Safety of Residues of Veter...[ Price : $8.95]
FDA approves a CorTec IDE to allow the University of Washington School of Medicine to conduct a study involving the closed-loop Br...[ Price : $8.95]
Federal Register notice: FDA announces a 7/11 public workshop entitled Evaluating Immunosuppressive Effects of In Utero Exposure t...